IMAX Stock Cash Flow Statements

IMAX Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

IMAX Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

operating activities
net income	12,235,000	8,150,000	6,866,000	15,343,000	5,073,000	5,420,000	3,311,000	15,019,000	9,613,000	5,123,000	4,081,000	-7,757,000	-4,251,000	-11,950,000	13,379,000	-6,344,000	-6,112,000	-10,500,000	-19,544,000	-48,484,000	-30,047,000	-59,411,000	21,352,000	10,896,000	13,836,000	12,487,000	3,771,000	7,502,000	10,255,000	12,067,000	8,698,000	2,898,000	1,809,000	-887,000	12,076,000	4,384,000	10,683,000	12,177,000	26,245,000	10,514,000	26,380,000	1,485,000	22,514,000	5,297,000	12,679,000	14,990,000	11,080,000	2,588,000	6,329,000		-7,447,000	-4,571,000	-4,780,000
adjustments to reconcile net income to cash from operating activities:
depreciation and amortization	15,896,000	14,913,000	16,601,000	14,900,000	18,838,000	15,164,000	13,545,000	19,279,000	13,878,000	13,320,000	13,998,000	15,640,000	14,282,000	12,741,000	15,512,000	14,899,000	12,685,000	12,986,000	12,312,000	14,112,000	11,930,000	15,252,000	17,987,000	15,696,000	15,593,000	14,211,000	15,453,000	13,950,000	14,513,000	13,521,000	27,040,000	14,413,000	13,266,000	12,088,000	12,306,000	12,115,000	11,626,000	10,438,000	11,612,000	10,467,000	11,091,000	9,633,000	9,819,000	7,992,000	8,084,000	8,038,000	9,200,000	7,466,000	7,143,000	-12,776,262	6,563,000	3,236,000	2,995,000
amortization of deferred financing costs	492,000	492,000	491,000	493,000	493,000	492,000	493,000	492,000	625,000	625,000	712,000	712,000	730,000	1,023,000	764,000	741,000
credit loss (reversal) expense	-183,000	-126,000	-10,000												933,000	-3,317,000
write-downs, including asset impairments	854,000	193,000	939,000	635,000	2,290,000	109,000
deferred income tax expense						571,000											-125,000	158,000	476,000			5,627,000
share-based and other non-cash compensation	7,492,000	5,275,000	5,948,000	5,508,000	6,970,000	4,783,000	6,400,000	5,297,000	7,398,000	5,135,000	8,063,000	5,544,000	7,777,000	6,189,000	7,521,000	6,226,000	6,911,000	5,421,000	5,693,000	5,495,000
unrealized foreign currency exchange (gain) loss			-2,243,000							-78,000									-961,000						10,000	-24,000										377,000	-26,000	-557,000							-177,000
realized and unrealized investment gain	-33,000	-32,000	-33,000	-32,000
changes in assets and liabilities:
accounts receivable	-3,688,000	-15,014,000	6,104,000	8,509,000	18,994,000	-4,502,000	485,000	-11,923,000	-2,843,000	12,374,000	-10,953,000	-3,305,000	-12,091,000	-2,654,000	-28,117,000	-13,287,000	2,695,000	-13,744,000	3,247,000	-6,621,000
inventories	-5,059,000	1,032,000	4,680,000	90,000	-1,599,000	-4,672,000	13,486,000	-7,653,000	-172,000	-5,946,000	4,602,000	-3,182,000	-6,415,000	-534,000	10,798,000	-1,214,000	1,430,000	437,000	11,915,000	6,609,000
film assets	-3,922,000	-7,396,000	-7,230,000	-5,151,000	-7,829,000	-4,912,000	-5,819,000	-5,334,000	-5,357,000	-3,884,000	-5,424,000	-3,754,000	-5,313,000	-5,107,000	-4,775,000	-4,227,000	-3,595,000	-2,213,000	-1,488,000	-2,120,000
deferred revenue	1,726,000	1,390,000	-915,000	-8,996,000	1,678,000	-6,075,000	788,000	-1,415,000	-5,861,000	2,606,000	-5,583,000	-698,000	-4,461,000	-830,000	-5,157,000	-987,000	-5,723,000	5,276,000	-11,870,000	-4,566,000
changes in other operating assets and liabilities	-2,085,000	-2,215,000	-21,421,000	5,315,000	-1,702,000	-17,384,000	-31,848,000	15,002,000	-10,799,000	-8,344,000	4,349,000	4,131,000	2,507,000	-10,186,000	9,548,000	5,233,000	-12,980,000	-4,155,000	-531,000	-11,889,000
net cash from operating activities	23,230,000	6,951,000	11,485,000	35,282,000	35,038,000	-10,968,000	4,007,000	28,753,000	4,637,000	21,218,000	16,840,000	5,774,000	-1,510,000	-3,783,000	25,647,000	-2,566,000	-6,065,000	-10,951,000	7,807,000	-9,938,000	-26,846,000	5,966,000	23,119,000	18,740,000	49,186,000	-669,000	41,902,000	21,416,000	31,191,000	15,463,000	21,947,000	26,199,000	37,837,000	-617,000	32,568,000	9,237,000	31,103,000	4,964,000	41,885,000	23,302,000	12,429,000	6,069,000	14,735,000	36,620,000	19,720,000	34,068,000	9,416,000	10,426,000	12,656,000	4,976,779	256,000	-5,857,000	618,000
capex	-2,361,000	-1,645,000	-4,612,000	-1,126,000	-1,586,000	-1,104,000	-3,950,000	-1,532,000	-645,000	-364,000	-3,176,000	-2,314,000	-2,206,000	-728,000	-1,237,000	-988,000	-899,000	-466,000	-39,000	-64,000	-323,000	-271,000	-1,893,000	-1,353,000	-1,938,000	-2,237,000	-6,001,000	1,265,000	-2,044,000	-6,588,000	-7,787,000	-6,585,000	-5,703,000	-4,068,000	-5,245,000	-1,561,000	-3,887,000	-4,585,000	-4,814,000	-3,523,000	-12,338,000	-22,582,000	-15,418,000	-8,105,000	-3,456,000	-824,000	-1,401,000	-374,000	-1,119,000	0	-610,000	-624,000	-99,000
free cash flows	20,869,000	5,306,000	6,873,000	34,156,000	33,452,000	-12,072,000	57,000	27,221,000	3,992,000	20,854,000	13,664,000	3,460,000	-3,716,000	-4,511,000	24,410,000	-3,554,000	-6,964,000	-11,417,000	7,768,000	-10,002,000	-27,169,000	5,695,000	21,226,000	17,387,000	47,248,000	-2,906,000	35,901,000	22,681,000	29,147,000	8,875,000	14,160,000	19,614,000	32,134,000	-4,685,000	27,323,000	7,676,000	27,216,000	379,000	37,071,000	19,779,000	91,000	-16,513,000	-683,000	28,515,000	16,264,000	33,244,000	8,015,000	10,052,000	11,537,000	4,976,779	-354,000	-6,481,000	519,000
investing activities
purchase of property, plant and equipment	-2,361,000	-1,645,000	-4,612,000	-1,126,000	-1,586,000	-1,104,000	-3,950,000	-1,532,000	-645,000	-364,000	-3,176,000	-2,314,000	-2,206,000	-728,000	-1,237,000	-988,000	-899,000	-466,000	-39,000	-64,000	-323,000	-271,000	-1,893,000	-1,353,000	-1,938,000	-2,237,000	-6,001,000	1,265,000	-2,044,000	-6,588,000	-7,787,000	-6,585,000	-5,703,000	-4,068,000	-5,245,000	-1,561,000	-3,887,000	-4,585,000	-4,814,000	-3,523,000	-12,338,000	-22,582,000	-15,418,000	-8,105,000	-3,456,000	-824,000	-1,401,000	-374,000	-1,119,000		-610,000	-624,000	-99,000
investment in equipment for joint revenue sharing arrangements	-2,920,000	-11,746,000	-2,613,000	-11,971,000	-5,315,000	-4,442,000	-7,295,000	-6,672,000	-1,876,000	-2,157,000	-5,260,000	-5,892,000	-4,064,000	-4,587,000	-4,733,000	-2,964,000	-857,000	-1,540,000	-1,365,000
acquisition of other intangible assets	-2,143,000	-1,233,000	-3,645,000	-1,611,000	-1,597,000	-1,594,000	-2,926,000	-1,940,000	-1,718,000	-1,760,000	-1,148,000	-1,566,000	-1,129,000	-551,000	-693,000	-768,000	-1,124,000	-1,507,000	-243,000	-440,000	-359,000	-862,000	-1,057,000	-753,000	-581,000	-540,000	-5,498,000	-1,493,000	-1,150,000	-555,000	-1,275,000	-1,315,000	-1,033,000	-1,591,000	-1,856,000	-1,240,000	-921,000	-770,000	-1,443,000	-650,000	-2,307,000	-665,000	-939,000	-1,009,000	-780,000	-823,000	-1,655,000	-2,568,000	-18,198,000
net cash from investing activities	-7,424,000	-14,624,000	-10,870,000	-14,708,000	-8,498,000	-7,140,000	-13,126,000	-10,144,000	-4,239,000	-4,281,000	-12,884,000	-22,411,000	-7,399,000	-10,597,000	-6,663,000	-4,720,000	-2,880,000	14,256,000	-1,647,000	-1,885,000	-3,010,000	-2,713,000	-12,340,000	-10,970,000	-15,038,000	-27,646,000	-23,599,000	-14,483,000	-6,839,000	-11,953,000	-16,264,000	-25,888,000	-17,239,000	-14,206,000	-26,398,000	-7,625,000	-21,520,000	-9,343,000	-13,762,000	-15,529,000	-21,443,000	-28,062,000	-16,780,000	-16,721,000	-12,319,000	-3,797,000	-8,992,000	-10,411,000	-31,087,000	2,253,263	-900,000	-862,000	-492,000
financing activities
revolving credit facility borrowings	6,000,000	23,000,000		4,000,000	6,000,000	45,000,000		315,000	5,000,000	25,717,000	32,981,000				0	0
repayments of revolving credit facility borrowings	-8,000,000	-10,000,000	-10,000,000	-11,000,000			-10,191,000	-4,171,000	-7,706,000	-31,180,000	0				-7,366,000	0	-45,243,000	-255,000,000
repayments of other borrowings	-163,000	-209,000		-178,000
repurchase of common shares				0	-246,000	-17,856,000		-252,000	-355,000	-3,656,000									0	0	0	-36,624,000	0	-1,401,000			-25,027,000	0	-33,056,000	-13,396,000	-2,000	0			-16,140,000	-14,664,000	-41,096,000	-44,618,000	3,000				-694,000
repurchase of common shares - imax china
taxes withheld and paid on employee stock awards vested	-237,000	-9,505,000	0	0	-784,000	-4,194,000	-8,000	0	-225,000	-6,233,000	-294,000	0	-257,000	-3,136,000	-615,000	0	0	-3,045,000	-261,000	0	-15,000	-236,000	-82,000	-289,000	0	-219,000	0	-158,000	-251,000	-1,028,000	-382,000	-31,000	-41,000	-146,000	-298,000	-157,000
common shares issued - stock options exercised	100,000	948,000	5,193,000												0	0	59,000	824,000					13,000	12,000	1,576,000	803,000										3,614,000	2,842,000	740,000				11,407,000	7,162,000
net cash from financing activities	-3,754,000	4,234,000	-5,090,000	-7,560,000	-16,185,000	22,794,000		-4,588,000	-4,724,000	-15,037,000	6,081,000	-7,085,000	-44,475,000	-13,035,000	-22,233,000	-13,917,000	-43,925,000	-52,645,000	7,058,000	-2,165,000	-3,489,000	239,163,000	-3,746,000	-12,107,000	-50,888,000	9,623,000	-10,862,000	-6,013,000	-37,347,000	-16,640,000	-4,347,000	-823,000	-52,865,000	499,000	-19,497,000	-11,707,000	-41,360,000	-53,218,000	171,398,000	-37,238,000	15,185,000	55,870,000	14,811,000	-1,354,000	-15,597,000	-24,208,000	1,551,000	3,405,000		1,934,706	-513,000
effects of exchange rate changes on cash	130,000	-84,000	563,000	-62,000	180,000	131,000	-103,000	316,000	346,000	-55,000					-48,000	86,000	-799,000	-245,000	-1,036,000	199,000	54,000	377,000	-97,000	434,000	107,000	186,000	534,000	-347,000	458,000	-16,000	-319,000	-24,000	30,000	46,000	-18,000	118,000	106,000	-100,000	567,000	443,000	-130,000	-38,000	32,000	73,000	82,000	-193,000	17,000	30,000	6,000	-30,970	53,000	-25,000	3,000
increase in cash and cash equivalents during period	12,182,000	-3,523,000		12,952,000	10,535,000	4,817,000				1,845,000						-21,117,000	-53,669,000	-49,585,000		-13,789,000	-33,291,000	242,793,000														-9,977,000	-31,671,000	-57,697,000
cash and cash equivalents, beginning of period	0	100,592,000		0	0	76,200,000		0	0	97,401,000		0	0	189,711,000		0	0	317,379,000		0	0	109,484,000		0	0	141,590,000		0	0	158,725,000		0	0	204,759,000		0	0	317,449,000		0	0	106,503,000		0		0	0	18,138,000			0	0	25,123,000
cash and cash equivalents, end of period	12,182,000	97,069,000		12,952,000	10,535,000	81,017,000		14,337,000	-3,980,000	99,246,000		-22,961,000	-52,188,000	162,300,000		-21,117,000	-53,669,000	267,794,000		-13,789,000	-33,291,000	352,277,000		-3,903,000	-16,633,000	123,084,000		573,000	-12,537,000	145,579,000		-536,000	-32,237,000	190,481,000		-9,977,000	-31,671,000	259,752,000		-29,022,000	6,041,000	140,342,000		18,618,000		5,870,000	1,992,000	21,588,000			-329,000	-8,942,000	25,252,000
unrealized foreign currency exchange loss		289,000						-123,000						58,000				113,000																					69,000	-135,000	-500,000	1,351,000		783,000
deferred income tax benefit			1,708,000	383,000				-445,000	-3,086,000	-193,000
interest in film classified as a financial instrument											0	0	0	-4,731,000
proceeds from sale of equity securities																	0	17,769,000
acquisition of ssimwave, net of cash and cash equivalents acquired
proceeds from revolving credit facility borrowings
proceeds from other borrowings
repayment of other borrowings						-156,000
credit facility amendment fees paid											-2,000	-249,000	-245,000	-1,783,000	-53,000	-442,000	0	-32,000	-47,000	-67,000							0	54,000											-223,000	-149,000	-158,000	-1,003,000							-9,000
repurchase of common shares, imax corporation											-26,543,000	-4,226,000	-43,083,000	-6,272,000
repurchase of common shares, imax china											0	-1,199,000	0	-1,844,000	-5,044,000				0	-2,000	-641,000	-891,000	-5,000	-2,344,000
principal payment under finance lease obligations			-29,000				0				-58,000	0
dividends paid to non-controlling interests							0	0			-3,000					-2,928,000			0	-2,096,000			0	-2,118,000
increase in cash and cash equivalents during year
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
credit loss expense					139,000	35,000		523,000	846,000	220,000				7,229,000				305,000	3,026,000	3,925,000	1,440,000	10,217,000
unrealized foreign currency exchange gain						33,000									-299,000						89,000	223,000					225,000	-67,000	438,000	35,000		-401,000	-291,000	-171,000													668,000	-1,388,000	-3,015,000
realized and unrealized investment gains						-30,000				-44,000		-35,000	-30,000	-34,000
other borrowings								0	0	315,000
credit loss expense (reversal)											398,000	808,000
deferred income tax (benefit) expense													-191,000	-109,000
acquisition of ssimwave inc., net of cash and cash equivalents acquired
proceeds from issuance of convertible notes															0	0	0	223,675,000
debt issuance costs related to convertible notes															2,000	-921,000
purchase of capped calls related to convertible notes															0	0	0	-19,067,000
net cash from by financing activities
decrease in cash and cash equivalents during year
write-downs								398,000	170,000	304,000		275,000	5,051,000	381,000	886,000	416,000	249,000	213,000	4,390,000	6,533,000	2,403,000	4,403,000																												-686,683	718,000	-31,000	6,000
unrealized investment gains								-364,000
decrease in cash and cash equivalents during period												-22,961,000	-52,188,000	-27,411,000										-3,903,000	-16,633,000	-18,506,000		573,000	-12,537,000	-13,146,000		-536,000	-32,237,000	-14,278,000
realized and unrealized investment (gains) losses															-29,000	-30,000	-33,000	-5,248,000
equity in losses of investees																				1,329,000	0	529,000
treasury stock purchased for future settlement of restricted share units																										-4,207,000		1,039,000	1,356,000	-5,992,000		1,026,000	-4,633,000	-779,000		7,000
effects of exchange rate changes on cash and cash equivalents												761,000	1,196,000	4,000
equity in losses (income) of investees
proceeds from sale of (investment in) equity securities
issuance of subsidiary shares to non-controlling interests																							0	0																			4,060,000	0
dividends paid to imax china non-controlling interests
proceeds from sale of equity investment
settlement of restricted share units and options																			-260,000	-58,000	-1,090,000	-1,667,000	-1,206,000	-970,000	-2,632,000	-4,987,000	1,651,000	-1,038,000	-1,356,000	-173,000	-4,965,000	-1,318,000	-2,890,000	-11,158,000	-9,513,000	-7,000
treasury stock repurchased for future settlement of restricted share units																			260,000	58,000	1,090,000	-1,419,000	-2,466,000	3,000
cash provided by:
adjustments to reconcile net income to cash from operations:
loss in fair value of investments																			1,142,000
investment in equity securities																							0	0	0	-15,153,000
increase in revolving credit facility borrowings																			7,366,000
repayment of revolving credit facility borrowings
loss in fair value of equity securities
purchase of equipment for joint revenue sharing arrangements																					-2,328,000	-1,580,000
increase in credit facility borrowings
repayment of credit facility borrowings
share and other non-cash compensation																						4,309,000
change in fair value of equity securities																						4,539,000
investment in film assets																						-3,064,000	-8,032,000	-7,191,000	-4,474,000	-3,740,000	-960,000	-4,021,000	-11,960,000	-6,259,000	-3,959,000	-11,097,000	-16,255,000	-3,334,000	-8,146,000	-3,272,000	-6,971,000	-3,919,000	-3,050,000	-4,665,000	-4,391,000	-3,013,000	-10,835,000	-3,251,000	-3,309,000	-2,367,000	-7,183,000	-3,958,000	-3,442,000	8,153,619	-2,575,000	-4,250,000	-1,340,000
changes in other non-cash operating assets and liabilities																						23,342,000	-21,643,000	-7,757,000	10,576,000	-27,105,000	12,790,000	-129,000	9,604,000	-9,818,000	-20,294,000	3,269,000	25,164,000	-17,280,000	-1,370,000	-14,105,000	7,347,000	-22,746,000	4,678,000	-1,985,000	-29,466,000	-9,805,000	-12,315,000	21,591,000	-6,590,000	3,097,000	-11,914,000	145,000	-1,187,000	-5,819,976	3,501,000	188,000	2,139,000
increase in bank indebtedness																						280,000,000	0	0	0	35,000,000	30,000,000												7,722,000	0	6,197,000	11,371,000			0	0	5,000,000	4,917,000	15,500,000
repayment of bank indebtedness																							0	-5,000,000	-35,000,000	-15,000,000	-10,000,000	-39,667,000	-500,000	-500,000	-500,000	-500,000	-500,000	-500,000	-500,000	-500,000	-500,000	-500,000							-19,000,000	-25,000,000	-5,000,000	-5,000,000	0
write-downs, net of recoveries																							3,822,000	1,118,000	1,169,000	697,000	9,229,000	855,000	650,000	1,036,000	3,948,000	12,465,000	9,145,000	4,010,000	3,037,000	1,654,000	601,000	648,000	797,000	1,471,000	1,329,000	128,000	3,541,000	174,000	91,000	597,000	438,000	481,000	1,113,000
deferred income taxes
stock and other non-cash compensation																							6,173,000	5,687,000	7,186,000	4,524,000	5,483,000	6,320,000	6,779,000	5,141,000	5,159,000	6,346,000	6,910,000	5,660,000	8,690,000	7,882,000	6,347,000	8,667,000	7,175,000	4,343,000	5,195,000	5,666,000	3,858,000	3,519,000	3,439,000	2,931,000	3,868,000	3,982,000	2,841,000	-3,054,211	1,053,000	197,000	1,809,000
income from equity-accounted investments																							-59,000	368,000	238,000	183,000	-114,000	103,000	0	106,000	-233,000	218,000	165,000	156,000	-84,000	789,000	1,162,000	818,000	1,082,000	833,000	1,138,000	785,000	701,000	499,000	324,000	334,000
(gain) loss on non-cash contribution to equity-accounted investees																							0	-534,000	-100,000	-99,000
investment in joint revenue sharing equipment																							-9,390,000	-8,864,000	-12,519,000	-9,716,000	-12,100,000	-14,255,000	-3,645,000	-4,810,000	-7,096,000	-17,988,000	-10,003,000	-7,547,000	-17,386,000	-4,824,000	-16,712,000	-3,988,000	-7,505,000	-9,356,000	-6,798,000	-4,815,000	-930,000	-5,107,000	-8,083,000	-2,150,000	-5,936,000	-7,088,000	-10,858,000
change in deferred income taxes																								-261,000	608,000	688,000	-4,074,000	-3,196,000	812,000	-465,000	1,128,000	-2,012,000	-2,175,000	-958,000	5,457,000	-488,000	156,000	-185,000	-6,433,000	2,865,000	2,041,000	191,000	-2,530,000	368,000	5,179,000	5,880,000	3,014,000	651,000	2,395,000			-73,000	-76,000
change in fair value of equity investment																								490,000
movement in fair value of financial instruments																										-2,491,000
repurchase of subsidiary shares from a non-controlling interest																										-1,767,000
issuance of subsidiary shares to a non-controlling interest																												850,000	2,247,000	4,449,000										0	0	40,000,000
gain on non-cash contribution to equity-accounted investees																															99,000	100,000	99,000	99,000	-66,000	-99,000	178,000	-377,000	-290,000	-406,000	-388,000	-352,000	-351,000						0
investment in new business ventures																															-106,000	0	-500,000	-1,000,000					0				0		0	0	0	-381,000	-912,000
common shares issued—stock options exercised																											0						1,337,000	13,082,000
taxes paid on secondary sales and repatriation dividend
loss on non-cash contribution to equity-accounted investees																												99,000	100,000	99,000
dividend paid to non-controlling shareholders																												-2,311,000
exercise of stock options																																							11,771,000
issuance of subsidiary shares to non-controlling interests - private offering
share issuance costs from the issuance of subsidiary shares to non-controlling interests - private offering
issuance of subsidiary shares to non-controlling interests - public offering
share issuance expenses - public offering
taxes paid on secondary sale and repatriation dividend																																				0	0	-2,991,000
income from discontinued operations, net of tax
net cash from operating activities from discontinued operations																																											0	0						773,692
proceeds from sale of business venture
settlement of restricted share units																																						-5,849,000			-1,083,000	-3,905,000	0	0
gain on curtailment of postretirement benefit plan
treasury stock repurchased for settlement of share based compensation
net income from discontinued operations
share issuance costs from the issuance of subsidiary shares to a non-controlling interest																																								0	0	-2,000,000
treasury stock purchased for settlement of share based compensation
increase in cash and cash equivalents during the period																																								-29,022,000	6,041,000	33,839,000		18,618,000		5,870,000	1,992,000	3,450,000
common shares issued — stock options exercised																																																3,488,000
share issuance costs from the issuance of subsidiary shares to non-controlling interests																																											0	0
proceeds from disgorgement of stock sale profits
share issuance expenses
net (income) income from discontinued operations																																												0
benefit from arbitration award																																																	0
gain on curtailment of postretirement benefits
change in cash surrender value of life insurance
cash surrender value of life insurance
acquisition of other assets
loss on equity-accounted investments																																																459,000
items not involving cash:
loss on repurchase of senior notes due december 2010
repurchase of senior notes due december 2010
common shares issued—public offerings, net of offering expenses paid
common shares issued— stock options exercised
shelf registration fees paid
net cash provided (used in) by financing activities
foreign currency exchange (gain) loss
net earnings
gain on sale of property, plant and equipment
proceeds from sale of property, plant and equipment
common shares issued — public offerings, net of offering expenses paid
common shares issued — private offering
debt modification fees paid
fees paid pertaining to amended credit facility agreement
foreign currency exchange gain
gain on repurchase of senior notes due december 2010
investment in joint venture
repayments of bank indebtedness
purchases of short-term investments																																																		6,450,543	-2,182,000	-2,151,000	-2,124,000
proceeds from maturities of short-term investments																																																		-6,439,428	2,174,000	2,150,000	2,124,000
net cash from investing activities from discontinued operations
financing costs related to senior notes due 2010																																																		2,082,570	-653,000
net income (income) from discontinued operations
write-downs net of recoveries
common shared issued — public offering
increase in cash and cash equivalents, during the period
foreign currency exchange loss
net earnings from discontinued operations
accrued interest on short-term investments
debt modification fees
increase in cash and cash equivalents, during the year																																																					129,000
common shares issued - private offering
receivable provisions, net of recoveries
common shares issued																																																		-147,580	140,000
purchase of property, plant and equipment, net of proceeds
recovery of deferred income tax valuation allowance
non-cash foreign exchange gain																																																			-502,000	-514,000	-109,000
interest on short-term investments																																																			-19,000	-23,000	-26,000
increase in cash surrender value of life insurance
increase in other assets																																																			-187,000	-129,000	-245,000
increase in other intangible assets																																																			-95,000	-108,000	-148,000
decrease in cash and cash equivalents, during the period																																																			-329,000
net (earnings) from discontinued operations
(increase) in cash surrender value of life insurance
decrease in cash and cash equivalents from continuing operations
increase in cash and cash equivalents provided by discontinued operations
increase in cash and cash equivalents from continuing operations																																																					129,000
increase in cash and cash equivalents provided by investing activities from discontinued operations
loss on retirement of notes
non-cash foreign exchange (gain) loss
premium on repayment of notes
changes in restricted cash
recovery on long-term investments
repayment of old senior notes due 2005
increase in cash and cash equivalents from discontinued operations

We provide you with 20 years of cash flow statements for IMAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IMAX stock. Explore the full financial landscape of IMAX stock with our expertly curated income statements.

The information provided in this report about IMAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.